Additional file 3: Figure S2. of Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors
Alicja Pawlak
Ewa Ziolo
Anna Fiedorowicz
Klaudyna Fidyt
Leon Strzadala
Wojciech Kalas
10.6084/m9.figshare.c.3609257_D2.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_Figure_S2_of_Long-lasting_reduction_in_clonogenic_potential_of_colorectal_cancer_cells_by_sequential_treatments_with_5-azanucleosides_and_topoisomerase_inhibitors/4357157
Combinatorial treatments increase apoptosis-associated DNA fragmentation in CRC cells. Representative histograms of HCT116, DLD-1, and HT-29 cells after sequential treatments with 1 μM 5-aza-dC and 5-50 μM etoposide. Figure 1a shows the treatment scheme. (PDF 208 kb)
2016-11-16 05:00:00
5-azacytidine
Akt
combinatorial therapy
Decitabine
DNA methylation
Doxorubicin
epigenetics
Etoposide
Irinotecan
Mitoxantrone